212 papers
Immunology explores the intricate defense systems that keep our bodies safe from infections and disease. This field examines how our immune cells recognize threats, coordinate responses, and maintain a delicate balance between fighting invaders and avoiding self-harm. From understanding vaccine mechanisms to investigating autoimmune disorders, these studies reveal the dynamic biology protecting human health every day.
On Gist.Science, we ensure these critical discoveries remain accessible to everyone. We automatically process every new preprint in this category as it appears on bioRxiv, transforming complex research into both plain-language explanations and detailed technical summaries. This approach allows readers to grasp the core findings without getting lost in dense jargon, while still providing the depth needed for scientific inquiry.
Below are the latest immunology papers from bioRxiv, each accompanied by our curated summaries to help you navigate the newest breakthroughs in the field.
This retrospective study of 376 adults with newly diagnosed Crohn's disease identifies lower BMI, lower HDL-C, and higher triglycerides as independent metabolic drivers associated with increased disease activity and a higher risk of complications, demonstrating that models using these specific parameters outperform ratio-based approaches in predicting clinical outcomes.
This study reveals that the persistence of memory T cells in the spleen and bone marrow relies on heterogeneous signaling pathways, where tissue-resident subsets depend on integrin-mediated adhesion coupled with either PI3K/AKT or NF-κB signaling, while non-resident subsets additionally require IL-7/IL-15 Jak signaling.
This study identifies fully human monoclonal antibodies, specifically W010 and W014, that target unique epitopes on the West Nile virus envelope protein to provide potent pre- and post-exposure protection against West Nile and related orthoflaviviruses, offering promising candidates for antibody-based interventions.
This study demonstrates that a gain-of-function mutation in the SKAP2 gene drives hyperactive integrin signaling in myeloid cells, leading to enhanced antigen presentation and a type 1 interferon-driven inflammatory response that accelerates type 1 diabetes and broader autoimmunity in mouse models.
This study reveals that the MLL1-MENIN complex preserves CD8 T cell memory through a noncanonical, methyltransferase-independent mechanism that sustains the TOX-BTLA-TCF1 axis to restrain cytokine-driven AKT activation and prevent the loss of stem cell-like memory potential.
This study presents a comprehensive human neonatal CITE-seq atlas that reveals a critical immune transition at 32 weeks' gestation, shifting from a CD15+ myeloid-dominated state in extremely preterm infants to an interferon-primed immunity in more mature neonates, thereby defining gestational age-specific immune programs and vulnerabilities.
This study reveals that diverse extracellular bacterial pathogens commonly utilize the lymphatic system to disseminate from soft tissue infections to sequential draining lymph nodes and systemic organs, challenging the traditional view that lymph nodes primarily function to trap and eliminate such bacteria.
This study establishes a novel human iPSC-derived co-culture system where direct contact between macrophages and hepatocytes drives reciprocal maturation into Kupffer cell-like and functional hepatocyte phenotypes, creating a physiologically relevant model for investigating liver biology and immune-mediated drug toxicity.
This study reveals that *Staphylococcus aureus* biofilms impair macrophage immune responses by reducing cGAS expression rather than degrading signaling molecules, and demonstrates that directly activating STING with 2'3'-cGAMP bypasses this defect to restore interferon responses, offering a promising therapeutic strategy for chronic implant-related infections.
This study presents six engineered mouse models containing humanized antibody repertoires with diverse, long CDR H3s to serve as preclinical platforms for testing and optimizing HIV-1 vaccine immunogens capable of eliciting broadly neutralizing antibodies.